Motion Seeks To Centralize All Seresto Flea and Tick Collar Lawsuits in MDL

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has been asked to consolidate all lawsuits filed throughout the federal court system which allege Seresto flea and tick collars poisoned pets and humans, requesting that the growing number of claims be centralized before one judge for coordinated discovery and pretrial proceedings.

Seresto flea collars are designed to release small amounts of pesticide onto the skin of cats and dogs for months at a time; to kill fleas, ticks and other pests. However, a report published earlier this year raised serious concerns about problems associated with the products, disclosing for the first time that more than 75,000 adverse health reactions have been reported to federal regulators among humans and pets after coming into contact with Seresto flea and tick collars, including nearly 1,700 pet deaths.

The manufacturers, Elanco Animal Health, Inc. and Bayer Healthcare, face at least 12Seresto flea and tick collar lawsuits filed in federal courts nationwide, and that number is expected to grow significantly in the coming months and years, given the high number of pet deaths and illnesses allegedly caused by the flea tick collars.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

On April 27, one plaintiff, Laura Revolinsky, filed a Motion to Transer (PDF) with the JPML, requesting the creation of a Seresto collar multidistrict litigation (MDL) in New Jersey federal court, where all of the cases would be consolidated for discovery and pretrial proceedings.

Such coordination is common in complex product liability litigation, where a large number of claims have been presented by former users of the same product, alleging similar injuries. Centralizing the Seresto flea and tick collar claims would help avoid duplicative discovery, prevent contradictory rulings from different judges, and serve the convenience of the parties, witnesses, and the courts, according to the motion.

Revolinsky filed a class action lawsuit on April 22, after her Cavalier King Charles Spaniel died while wearing a Seresto collar, alleging the manufacturer knew about the poisoning risks, but failed to warn pet owners.

Earlier this month, the Center for Biological Diversity filed a Freedom of Information Act complaint with the U.S. Environmental Protection Agency (EPA), seeking to obtain information on thousands of Seresto collar problems reported by consumers nationwide. The Center says originally the EPA agreed to hand over the documents by the end of September 2020, but the documents never came.

The U.S. JPML is expected to consider oral arguments on the motion, including any response filed by the manufacturers, during a hearing this summer. The panel will then determine whether centralized management is appropriate at this early stage of the litigation, and the most appropriate forum for the pretrial proceedings.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted 3 days ago)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.

Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto
Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto (Posted 3 days ago)

Bayer and Monsanto prevailed in a Roundup lawsuit that went to trial in Philadelphia this week, after a jury found that exposure to the herbicide did not cause a man to develop non-Hodgkin's lymphoma.